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In this study whole plant aqueous extract of Solanum Xanthocarpum (HAESX) was investigated to assess its effect on 
humoral immune response along with interleukin-2 (IL-2) production and its expression in Wistar albino rats splenocytes 
culture. Anticancer potential of HAESX was investigated using rat lever hepatoma (N1S1 cancerous cell line). The effect of 
HAESX over humoral immune response was studied using four groups of five animals each (Group-I as control, Group -II 
orally fed with 125 mg/kg body weight, Group -III orally fed with 250 mg/kg body weight and Group -IV orally fed with 
500 mg/kg body weight of HAESX). Quantification of IL-2 was done by sandwich ELISA and its expression was detected 
by the real time PCR. SRB assay (Sulforhodamine B) was done for detecting the effect of HAESX on N1S1 cell line. Dose 
dependent decrease in antibody titer was observed and production of IL-2 was also decreased significantly. Suppression of 
IL-2 production at 250 µg/mL and 500 µg/mL dose was also confirmed by the Real time PCR. Relative fold change in the 
expression of IL-2 gene was 592.22 and 10.77 at 250, 500 μg/mL HAESX concentrations respectively with respect to 
control. Dose dependent suppression of percent growth of N1S1 cells with increasing concentrations (10, 20, 40 and 80 
µg/mL) of HAESX was found. It was concluded that S. xanthocarpum have the immunosuppressive, and anti cancer activity 
that can be further explore in treatment of various inflammatory and autoimmune disease.  
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India is enriched with mega diversity, over 7500 
medicinal plants including herbs and weeds have been 
enlisted and of which 2000 plants have been prized 
for their medicinal value in treating infectious 
diseases, metabolic disorders and immune diseases in 
humans and animals1. Charaka Saṃhita and Sushruta 
Samhita are two fundamental literatures of ancient 
Indian traditional systems of medicines that described 
the medicinal plants. During the last few decades the 
use of traditional systems of medicines has increased 
significantly in both developed and developing 
countries and presently it accounts for major part of 
the health care systems world wide2,3. People turn to 
traditional systems for complementary care because 
of its diversity, flexibility, availability, affordability 
and its widespread acceptance4,5. 
In traditional Indian and Chinese system of 
medicines Solanum plant species have been used  
for centuries as antiasthmatic, hepatoprotective,  
anti-inflammatory, anticancer, hypocholesterolaemic, 
antianaphylactic, antiandrogenic, antispermatogenic, 
insecticidal, antiaccelerator, antioxidant and many 
other diseases6. In Indian subcontinent many workers 
from time to time studied different species of genus 
Solanum plant and revealed that S. xanthocarpum and 
Solanum nigrum both have answers to treat the 
Asthma and atopic diseases such as hay fever and 
rhinitis7,8. Chinese worker found poysaccharide 
extracted from S. nigrum as antineoplastic agent9,10. 
Immunomodulatory properties of several medicinal 
plants used in Indian traditional medicines and other 
traditional systems have attracted many scientists to 
explore their effect on immune system of humans  
and animals11,12. Some of the common plants 
exhibiting immunomodulatory properties include  
S. xanthocarpum, Tinospora cortifolia, Cyperus 
rotuntus, Operculina turpethium, Picrorrhiza curroa, 
Melia azadirachta, Ocimum tenuiflorum, Zingiber 
officinale, Adhatoda vasica13. The Indian traditional 
system of medicine is lacking in answerable scientific 
basis such as mechanism of their actions, effects on 
host defense mechanism and how these herbal drugs —————— *Corresponding author 




cure metabolic disorders. It is now known that the 
cytokines and other informational bio molecules 
released by different cells essentially TH1, TH2, 
macrophages and NK-cells serve as the regulatory 
valve for immune responses and so can provide a 
mode of immunotherapy for readdressing variety of 
impaired responsiveness, autoimmune diseases and 
immune suppression14,15. 
The role of S. xanthocarpum known for its 
medicinal potential from ancient time in regulating or 
modulating the cytokines or other biomolecules for 
the betterment of immune system and for other 
defense mechanisms of the body is yet to establish 
emphatically so that this plant could be used 
scientifically for treating immunity related disorders. 
 
Materials and Methods 
 Chemicals 
Fetal Bovine Serum (FBS), Concanavalin A (Con 
A), TRI reagent, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and RPMI-1640 
medium were purchased from Sigma chemicals Co, 
USA. Rat IL-2 ELISA kit was obtained from R&D 
Systems, USA. Anti rat IgG-HRP conjugate antibody, 
revertaid reverse transcriptase and 2X SYBR green 
master mix were procured from Thermo Scientific, 
USA. Primers were designed from Xcelris, 
Ahmedabad, India. 
 Collection of plant 
S. xanthocarpum plants collected in the month of 
February-March from Mathura (India) ( 27o33’05.0”N 
&  77o38’11.3”E) and its adjoining areas was identified 
and authenticated by Dr Anuradha Upadhye of Agharkar 
research institute, Pune (Boucher deposition no. 26). 
Whole plant was dried in shade. Coarsely powdered 200 
g of SX was used for hot aqueous extraction by soxhlet 
apparatus at 100ºC for 8-10 h. The extracted solution 
was dried using rotary evaporator. 
 Experimental animals 
Wistar albino rats of both sexes weighing  
60-100 g reared and maintained in central animal 
house, GLA University, Mathura were used for 
immunomodulatory studies. 
 Determination of In vitro Humoral response 
against Salmonella. typhimurium ‘O’ antigen 
Humoral immune response was studied  using 4 
groups of Wistar albino rats with 5 rats in each group 
by sensitizing them with S. typhimurium ‘O’ antigen 
which were subsequently fed with 125 mg, 250 mg & 
500 mg/kg body weight of HAESX for 21 days. 
Preparation of S. typhimurium ‘O’ antigen for 
raising antisera27 
Smooth colonies of S. typhimurium grown on 
Tryptose agar medium were selected and inoculated 
in nutrient broth. Inoculated broth was incubated for  
8 h at 37°C and then centrifuged at 3000 rpm for  
20 min and supernatant was discarded and pellet was 
washed with normal saline thrice and then boiled at 
100°C for two h thirty min. This heated culture was 
then used as ‘O’ antigen for determination of humoral 
immune response in albino rats. 
 
Immunization of rats 
Experimental Wistar albino rats were divided in  
4 groups. In Group (I) as control, ‘O’ antigen was 
inoculated without feeding HAESX. Group II, III & 
IV were fed orally with HAESX respectively for  
21 days and were immunized with ‘O’ antigen. One 
week after last dose of ‘O’ antigen, blood serum was 
collected for determining antibody titer in albino rats 
against ‘O’ antigen by indirect ELISA. 
 
Determination of antibody titer by indirect ELISA 
Polystyrene micro titer plate (Nunc) are coated 
with Salmonella ‘O’ antigen and incubated overnight 
at 4°C. Following three washings with phosphate 
buffer saline (PBS) pH 7.2, 0.01M containing 0.05% 
tween-20 (PBS-T). Blocking was done using 1% 
bovine serum albumin dissolved in PBS, for 1½ h at 
37°C. Diluted serum samples (1:10 to 1:10,240) were 
added from 1st to 11th well of micro titer plate, 12th 
well was used as blank. 100 µL horse radish 
peroxidase (HRP) conjugated rabbit anti rat 
immunoglobulin –G (IgG) and substrate solution 
TMB (1:20) were serially added to the wells of micro 
plate, after 15 min 50 µL of 1M sulphuric acid was 
added to each well to stop the colour development 
The optical density was measured at 450-570 nm. 
Each step is followed by 2 h incubation at 37°C and 
three washings with wash buffer was done after  
each step 
 
Splenocyte preparation & IL-2 Induction in 
presence of HAESX 
Rat splenocytes were prepared as per the method 
suggested27. In vitro induction was done by Con A as 
mitogen (5 µg/mL) per well in 200 µL of 2x106 
spleen cells/mL in triplicate, cultured in RPMI-1640 
medium supplied with 10% FBS. 20 µg/mL,  
50 µg/mL, 100 µg/mL, 250 µg/mL and 500 µg/mL 
HAESX were added to respective wells of plate. The 
culture plate was incubated at 37°C for 48 h with  




5% CO2. Following incubation, culture supernatant 
was collected for quantitation of IL-2 using sandwich 
ELISA. 
 
Quantification of IL-2 using sandwich ELISA 
Cytokine were quantified by sandwich ELISA 
using the standard method. The collected supernatant 
from Con A activated splenocyte culture were thawed 
and used for ELISA. OD was measured at dual wave 
length 450-570 nm. Each experiment was performed 
in triplicate. 
 
Quantification of IL-2 cytokine expression by Real 
time PCR 
 Isolation of mRNA from spleen cells 
Splenocytes (1x107 cells/mL) were isolated from 
control rat and HAESX (250, 500 µg/mL) fed rat and 
cultured in RPMI-1640 medium on culture plates in 
presence of Con A (5 µg/mL). RNA was extracted 
from control and 250, 500 µg/mL HAESX treated 
spleen cells as per protocol of TRI Reagent. 
 Real Time Polymerase chain reaction (qPCR) of 
cDNA 
The expression of IL-2 cytokine gene and β-actin 
as endogenous control in spleen cell were carried out 
by quantitative SYBR green real time PCR (qRT-
PCR) in CFX96 Touch Real-time PCR detection 
system ( Biorad, USA) by using specific primer of  
β-actin 5’-TGGAGAAGAGCTATGAGCTGC-3’/5’-
TCCACACAGAGTACTTGCGC-3’(315bp) and IL-2 
5’-AGCTGTTGCTGGACTTACAGG-3’/5’-AATTC 
CACCACAGTTGCTGG-3’(307bp). All the reactions 
were set in 20 µL of reaction volume in 8 strip tubes 
in triplicate. In short, 1 µL of cDNA template (50 ng 
total RNA equivalent) for each sample was assayed in 
triplicate along with no template control (NTC) and 
non-reverse transcription control (NRT). The reaction 
mixture contain 10 µL of 2X Hot start Veri QuestTM 
Fast SYBR Green PCR Master Mix with Flurescein 
(USB, Affymetrix, USA), 1 µL (10 pmol) of forward 
and reverse primer. PCR condition were : hold at 
50°C for 2 min, initial activation at 94°C for 30 s, 
annealing at 54°C for 30 s and extension at 72°C for 
30 s. After 39 cycles of amplification, final extension 
was done at 72°C for 7 min followed by melt curve 
analysis starting from 65°C to 90°C for 20 min with 
continuous imaging by CCD camera. 
Standardization and optimization of these primer 
were initially checked using conventional PCR using 
the same reaction condition as describe above 
(excluding melt curve analysis) and the products were 
verified by agarose gel electrophoresis in 1.5% TAE – 
Ethidium Bromide stained gel in the presence of  
50 bp DNA ladder (Hi-media, MBT084-200LN) size 
run at 60 V for 1-2 h. The amplicons were analyzed 
by Quantity OneR (Biorad) software. 
 
Real time QRT-PCR quantification  
Relative fold expression of IL-2 gene was 
determined by 2-ΔΔCT method27. The β-actin gene was 
taken as the endogenous control, and ∆ CT value were 
calculated by subtracting β-actin CT value from the CT 
value of specific target IL-2 cytokine for each sample. 
The average ∆ CT for sample collected from normal 
spleen cell was taken as the calibrator group (∆ CT 
calibrator group) for each sample. Then ∆∆ CT value 
were calculated by subtracting the average ∆ CT for 
normal spleen cells from ∆ CT   of normalized target 
values (∆ CT target group). 
 
In vitro anticancer activity of HAESX:  
For determining the In vitro anticancer activity of 
HAESX against the N1S1 rat hepatoma cell line was 
performed according to standard protocol16. 
Adriamycin was used as the standard drug and 
sulforhodamine was used to stain the cells. OD was 
measured at 510 nm by ELISA reader. Percent 
Growth was expressed as the ratio of average 
absorbance of the test well to the average absorbance 
of the control wells X 100.  
 
% of control cell growth = 
 mean OD sample –  mean OD day 0
mean OD negative control –  mean OD day 0  X 100 
 
% growth inhibition = 100 - % of control cell growth 
 
% cell killed =  
100 - mean OD sample/mean OD day 0 X 100 
 
Statistical analysis: 
Statistical analysis of data was done with one way 
analysis of variance (ANOVA) using SPSS version 
20.0 software and DMRT at p<.05 and .01 to 




 Determination of humoral immune response 
against S. Typhimurium (O) antigen 
Serum antibody titer in Wistar albino rats fed orally 
with different concentrations of HAESX (125 mg/kg/ 
250 mg/kg/500 mg/kg) was 960.00ab±184.75, 800.00a  
±160 & 400a ±138.56 respectively and dose dependent 




decline in serum antibody titer was found with respect 
to control (1600b±320.00) (Fig. 1). 
 
In vitro effect of HAESX on induction of IL-2 
cytokine 
Induction of IL-2 cytokine was evaluated by using 
Con A stimulated splenocytes in the presence of 
different concentrations of HAESX. Quantitation of 
IL-2 was done by ELISA using supernatant of 
splenocytes culture 48 h post treatment. This 
experiment revealed that IL-2 production suppressed 
with increase in HAESX concentration. High 
concentrations (500, 250 & 100 µg/mL) of HAESX 
induced 29%, 24.71% & 15.3% decrease in  
IL-2 respectively as shown in Fig. 2. 
 
Real time PCR analysis for expression of IL-2 
cytokine gene 
Down regulated expression of IL-2 obtained in 
supernatant of splenocytes culture treated with 250 µg 
and 500 µg/mL was further confirmed by m-RNA 
expression using spleen cells harvested after 24 h 
employing real time PCR and results were compared 
with control using β-actin as housekeeping gene. In 
present study, results of Real time –PCR were analyzed 
by comparative CT values. Target gene (IL-2) was 
taken along with β-actin as housekeeping gene and fold 
expression of IL-2 gene in presence of 250, 500 μg/mL 
HAESX of was calculated with respect to control by  
2-ΔΔCT method27. PCR efficiencies of β-actin and target 
gene IL-2 were assessed by estimating the standard 
curve for β-actin and IL-2. Cq value was found to be 
20.18, 20.18 and 21.29 for β-actin gene from normal 
spleen cells and spleen cells treated with 250 µg/mL 
HAESX and 500 µg/mL HAESX respectively. Cq 
value for IL-2 gene from normal spleen cells and 
spleen cells treated with 250 µg/mL HAESX and  
500 µg/mL HAESX were found to be 25.7, 28.2 and 
31.11 respectively. Fold change in the expression of 
target gene IL-2 was 592.22 and 10.77 at 250,  
500 μg/mL HAESX concentrations respectively with 
respect to control (untreated) IL-2 gene (Table 1). 
 In vitro anticancer activity of HAESX: Four 
concentrations (10, 20, 40 and 80 μg/mL) of HAESX 
were screened using N1S1 rat hepatoma cell line. 
Adriamycin was used as standard. Among the doses, 
40 and 80 μg/mL HAESX were found to be effective 
against N1S1 rat hepatoma cell line (Fig. 3). 
 
Table 1 — Expression of target gene (IL-2) in presence of 250 & 500 μg/mL HAESX with respect to IL-2 of untreated rat (control) 
S.N Gene Cq value/ 
CT  value Fold Change of target gene (IL-2)=2
-  
=(Target gene –Target internal control)-(Untreated control gene-
Untreated internal control) 
1. IL-2 control rat 25.70 - 
2. IL-2, HAE treated rat (250 µg/mL) 28.20 10.77 
3. IL-2, HAE  treated rat (500 µg/mL) 31.11 592.22 
4. β-actin control rat (internal control) 20.18 - 
5. β-actin, HAE treated rat (250 µg/mL) 20.75 - 




Fig. 1 — Effect of HAESX on Antibody titer 
 
  
Fig. 2 — In vitro effect of HAESX on IL-2 induction 
 
  
Fig. 3 — Effect of HAESX on rat hepatoma cell line N1S1 





Traditional use of medicinal herbs and weeds has 
been practice for the treatment of humans and animal 
diseases. However, the progress is not substantial due 
to doubts in the minds of scientific and medical 
fraternity regarding safety, efficiency, and quality of 
herbal drugs17. This may be due to lack of clinical 
experiments, molecular based scientific evidences and 
sub standardization of herbal drugs in terms of quality 
and efficacy. Therefore phytotherapy has not achieved 
the status parallel to modern medicines. In view of 
problem of drug resistance, there has been renewed 
interest in natural and herbal medicines worldwide18. 
This also be due to attention of scientist on the 
clinical experiments and exploration of importance of 
biomolecules and their signal networks on the lines  
of modern medicine systems by adopting latest 
methodologies and technologies. Modern medicine 
system does not cure all ailments specially chronic 
and degenerative diseases, immunological disorders 
and autoimmune diseases. There is alarming increase 
in incidence of respiratory diseases such as asthama, 
hay fever, rhinitis, chronic obstructive pulmonary 
disease (COPD) lung infection, lung cancer etc. 
resulting in respiratory distress ranging from acute to 
chronic conditions hampering  working capability and 
disability of persons to perform effective working. In 
addition respiratory distressed persons become prone 
to several degenerative and metabolic disorders19. 
In the present study herbal medicines were used in 
order to contain allergens’ and pollutants’ associated 
respiratory disorders. Modern drugs used to treat 
asthma and other related diseases have adverse effects 
on body organ and systems as well as on metabolism 
of the host20. Allopathic drugs relieve symptoms 
slowly for shorter period and their continued use have 
ill effects on heart such as dilation of left ventricle 
and weakening of myocardium which fail to pump 
blood with its full strength21. In Ayurveda medicinal 
plants viz. Argemone, Cassia, Clerodendrum, Eclipta, 
Euphorbia, Ficus etc22, reported to have medicinal 
value in respiratory infections, of these medicinal 
plants, S. xanthocarpum was selected for scientific 
based detailed study as it has several phytochemicals 
that show the pharmacological activity23.  
Present study includes assessment of humoral 
immune response (antibody mediated) against somatic 
‘O’ antigen of S. typhimurium by indirect ELISA test. 
Dose dependent significant suppression (p<0.05) in 
serum antibody titer was recorded in rats fed orally 
with increasing concentrations of HAESX (Fig. 1). 
This shows that HAESX has inhibitory effect on the 
antibody production which is in general monitored by 
TH2 lymphocytes. Several investigators24,25,26 narrated 
the immunomodulatory role of S. nigrum by studying 
antibody production as well as induction of cell 
mediated immune response but not at the molecular 
level  that influence these immune responses through 
inflammatory messanger molecules referred to as 
cytokines, interleukin and chemokines. In our opinion 
no study has been done showing effect of S. 
xanthocarpum or its components on cytokine 
induction and expression.  
In our current study, levels of IL-2 in HAESX 
treated rat splenocyte cell culture supernatants were 
determined by an enzyme linked immune sorbent 
assay (ELISA) using commercially available kit. A 
Dose dependent significant suppression (p<.01) in 
level of IL-2 cytokine in comparison to control was 
observed (Fig. 2). The major source of IL-2 is the 
CD4+T cell (TH) specifically TH1 subset. 
Physiological function of IL-2 is to promote the 
activation and proliferation of T cell and natural 
killer cells in autocrine and paracrine manner. IL-2 
also plays a role in suppressing T cell induced 
immune response27. The recent additional evidences 
suggest that IL-2 is not only as an activator of 
immune response but also participate as a key 
mediator of immune tollerence28, in these study it 
was explained that effects of essential fatty acid on 
down regulation of IL-2 and concluded that fatty 
acids show the anti-inflammatory actions by 
inhibiting the IL-2 production. This study was in 
agreement with our study that showed the down 
regulation of IL-2. It might be possible the HAESX 
might have the essential fatty acid that do the same 
function. Although this in vitro system can not 
accurately depict the kinetics of inflammatory 
process in the body of the host, it provides a plate 
form at least to understand in terms of cytokine 
mRNA expression, protein synthesis and release by 
Con A stimulated splenocytes. This investigation 
may have good relevance with respect to the 
potential of HAESX in regulating proinflammatory 
cytokines production.  
Anticancer activity of HAESX using N1S1 rat 
hepatoma cell line was also evaluated. Different 
concentrations (10, 20, 40 and 80 μg/mL) of HAESX 
were used to treat N1S1 rat hepatoma cell lines.  
40 μg/mL and 80 μg/mL concentrations inhibited the 




cell growth by 38.7% and 35.7% respectively as 
compared to control (Fig. 3). Antimetastatic activity 
of S. xanthocarpum was evaluated by using lung cell 
line29. Our work was in agreement with Several other 
workers who reported anti cancer activity of  
S. xanthocarpum, and S. nigrum30,31,32. 
 
Conclusion 
This study was conceptualized to understand 
immunomodulation with respect to cytokines 
expression. Present study provided molecular based 
scientific evidence to support Indian system of 
medicine for the use of Solanum plant species as 
potential medicinal value in treating chronic 
inflammatory diseases that include respiratory 
diseases (Asthma, Hay fever, Rhinitis, pulmonary 
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